ESSA Pharma Inc. — Director's Dealing 2021

Jan 27, 2021

SEC Form 4/A — Form 4/A

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2020-12-11

Reporting Person: Requadt Scott (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (Right to Buy)	$7.00	A	16500	Acquired	2030-12-11	Common Shares (16500)	Direct

Footnotes

F1: Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant.